BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 19081632)

  • 21. Immunobiology of human NKG2D and its ligands.
    González S; Groh V; Spies T
    Curr Top Microbiol Immunol; 2006; 298():121-38. PubMed ID: 16329186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Varicella-Zoster Virus and Herpes Simplex Virus 1 Differentially Modulate NKG2D Ligand Expression during Productive Infection.
    Campbell TM; McSharry BP; Steain M; Slobedman B; Abendroth A
    J Virol; 2015 Aug; 89(15):7932-43. PubMed ID: 25995251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation.
    Gilfillan S; Ho EL; Cella M; Yokoyama WM; Colonna M
    Nat Immunol; 2002 Dec; 3(12):1150-5. PubMed ID: 12426564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of soluble NKG2D ligands: proteolytic cleavage, exosome secretion and functional implications.
    Chitadze G; Bhat J; Lettau M; Janssen O; Kabelitz D
    Scand J Immunol; 2013 Aug; 78(2):120-9. PubMed ID: 23679194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of murine NK cell exhaustion through the activation of the DNA damage repair pathway.
    Alvarez M; Simonetta F; Baker J; Pierini A; Wenokur AS; Morrison AR; Murphy WJ; Negrin RS
    JCI Insight; 2019 Jun; 5(14):. PubMed ID: 31211693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of Polymorphisms of NKG2D Receptor and Its Ligands in Acute Myeloid Leukemia and Human Stem Cell Transplantation.
    Machuldova A; Holubova M; Caputo VS; Cedikova M; Jindra P; Houdova L; Pitule P
    Front Immunol; 2021; 12():651751. PubMed ID: 33868289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunobiology and conflicting roles of the human NKG2D lymphocyte receptor and its ligands in cancer.
    El-Gazzar A; Groh V; Spies T
    J Immunol; 2013 Aug; 191(4):1509-15. PubMed ID: 23913973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Importance of NKG2D-NKG2D ligands interaction for cytolytic activity of natural killer cell.
    Bae DS; Hwang YK; Lee JK
    Cell Immunol; 2012; 276(1-2):122-7. PubMed ID: 22613008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative genomics of the NKG2D ligand gene family.
    Kasahara M; Sutoh Y
    Immunol Rev; 2015 Sep; 267(1):72-87. PubMed ID: 26284472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NKG2D and its ligands.
    Obeidy P; Sharland AF
    Int J Biochem Cell Biol; 2009 Dec; 41(12):2364-7. PubMed ID: 19631280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity.
    Dunn C; Chalupny NJ; Sutherland CL; Dosch S; Sivakumar PV; Johnson DC; Cosman D
    J Exp Med; 2003 Jun; 197(11):1427-39. PubMed ID: 12782710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NKG2D ligands as therapeutic targets.
    Spear P; Wu MR; Sentman ML; Sentman CL
    Cancer Immun; 2013; 13():8. PubMed ID: 23833565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family.
    Steinle A; Li P; Morris DL; Groh V; Lanier LL; Strong RK; Spies T
    Immunogenetics; 2001; 53(4):279-87. PubMed ID: 11491531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinct mechanisms of tumor resistance to NK killing: of mice and men.
    Pardoll DM
    Immunity; 2015 Apr; 42(4):605-6. PubMed ID: 25902479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conformational plasticity revealed by the cocrystal structure of NKG2D and its class I MHC-like ligand ULBP3.
    Radaev S; Rostro B; Brooks AG; Colonna M; Sun PD
    Immunity; 2001 Dec; 15(6):1039-49. PubMed ID: 11754823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of NKG2D ligand expression on host immune responses.
    Champsaur M; Lanier LL
    Immunol Rev; 2010 May; 235(1):267-85. PubMed ID: 20536569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T cells gene-engineered with DAP12 mediate effector function in an NKG2D-dependent and major histocompatibility complex-independent manner.
    Teng MW; Kershaw MH; Hayakawa Y; Cerutti L; Jane SM; Darcy PK; Smyth MJ
    J Biol Chem; 2005 Nov; 280(46):38235-41. PubMed ID: 16169855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma.
    Doubrovina ES; Doubrovin MM; Vider E; Sisson RB; O'Reilly RJ; Dupont B; Vyas YM
    J Immunol; 2003 Dec; 171(12):6891-9. PubMed ID: 14662896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Posttranslational regulation of the NKG2D ligand Mult1 in response to cell stress.
    Nice TJ; Coscoy L; Raulet DH
    J Exp Med; 2009 Feb; 206(2):287-98. PubMed ID: 19171762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quercetin enhances susceptibility to NK cell-mediated lysis of tumor cells through induction of NKG2D ligands and suppression of HSP70.
    Bae JH; Kim JY; Kim MJ; Chang SH; Park YS; Son CH; Park SJ; Chung JS; Lee EY; Kim SH; Kang CD
    J Immunother; 2010 May; 33(4):391-401. PubMed ID: 20386467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.